Long acting beta adrenoceptor agonist

WikiDoc Resources for Long acting beta adrenoceptor agonist
Articles
Most recent articles on Long acting beta adrenoceptor agonist Most cited articles on Long acting beta adrenoceptor agonist Review articles on Long acting beta adrenoceptor agonist Articles on Long acting beta adrenoceptor agonist in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Long acting beta adrenoceptor agonist Images of Long acting beta adrenoceptor agonist Photos of Long acting beta adrenoceptor agonist Podcasts & MP3s on Long acting beta adrenoceptor agonist Videos on Long acting beta adrenoceptor agonist
Evidence Based Medicine
Cochrane Collaboration on Long acting beta adrenoceptor agonist Bandolier on Long acting beta adrenoceptor agonist TRIP on Long acting beta adrenoceptor agonist
Clinical Trials
Ongoing Trials on Long acting beta adrenoceptor agonist at Clinical Trials.gov Trial results on Long acting beta adrenoceptor agonist Clinical Trials on Long acting beta adrenoceptor agonist at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Long acting beta adrenoceptor agonist NICE Guidance on Long acting beta adrenoceptor agonist NHS PRODIGY Guidance FDA on Long acting beta adrenoceptor agonist CDC on Long acting beta adrenoceptor agonist
Books
Books on Long acting beta adrenoceptor agonist
News
Long acting beta adrenoceptor agonist in the news Be alerted to news on Long acting beta adrenoceptor agonist News trends on Long acting beta adrenoceptor agonist
Commentary
Blogs on Long acting beta adrenoceptor agonist
Definitions
Definitions of Long acting beta adrenoceptor agonist
Patient Resources / Community
Patient resources on Long acting beta adrenoceptor agonist Discussion groups on Long acting beta adrenoceptor agonist Patient Handouts on Long acting beta adrenoceptor agonist Directions to Hospitals Treating Long acting beta adrenoceptor agonist Risk calculators and risk factors for Long acting beta adrenoceptor agonist
Healthcare Provider Resources
Symptoms of Long acting beta adrenoceptor agonist Causes & Risk Factors for Long acting beta adrenoceptor agonist Diagnostic studies for Long acting beta adrenoceptor agonist Treatment of Long acting beta adrenoceptor agonist
Continuing Medical Education (CME)
CME Programs on Long acting beta adrenoceptor agonist
International
Long acting beta adrenoceptor agonist en Espanol Long acting beta adrenoceptor agonist en Francais
Business
Long acting beta adrenoceptor agonist in the Marketplace Patents on Long acting beta adrenoceptor agonist
Experimental / Informatics
List of terms related to Long acting beta adrenoceptor agonist

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

They are designed to replace the shorter acting B2-agonists such as salbutamol, as they have a duration of action of approximately 12 hours in comparison with the 4-6 hour duration of salbutamol, making them ideal candidates for twice-daily administration.

Indication

Long acting beta-adrenoceptor agonists are usually prescribed for moderate to severe persistent asthma patients or patients with COPD.

Types

Some long acting beta-adrenoceptor agonists are:

• Salmeterol
• Formoterol
• Bambuterol

Template:WikiDoc Sources